Clinical Trial

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Study acronym: N/Z
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Protocol Amendment History 2 changes
notable Trial sites expanded: 2 -> 20 locations 2026-07-10
critical Recruitment opened 2026-06-23
Trial Details
NCT Number NCT07489885
Lead Sponsor InventisBio Co., Ltd
Conditions Psoriasis
Enrollment 75 participants
Start Date 2026-06-03
Primary Completion 2027-08 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-09